NO950667L - Amniotisk membranpodning eller belegg for å forhindre adhesjon eller blödning fra indre organer - Google Patents

Amniotisk membranpodning eller belegg for å forhindre adhesjon eller blödning fra indre organer

Info

Publication number
NO950667L
NO950667L NO950667A NO950667A NO950667L NO 950667 L NO950667 L NO 950667L NO 950667 A NO950667 A NO 950667A NO 950667 A NO950667 A NO 950667A NO 950667 L NO950667 L NO 950667L
Authority
NO
Norway
Prior art keywords
layer
bleeding
amniotic
internal organs
coating
Prior art date
Application number
NO950667A
Other languages
English (en)
Other versions
NO950667D0 (no
Inventor
Ronald L Young
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NO950667D0 publication Critical patent/NO950667D0/no
Publication of NO950667L publication Critical patent/NO950667L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/40Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Et spesifikt behandlet amnlonlag, så som en amniotisk membran som forhindrer adhesjoner etter skade, så som kirurgiske skader og som forhindrer blødning av indre organer forårsaket av skade er beskrevet. I det amnlonlske laget er det cellulære momolaget fjernet og eksponerer grunnmembranen, collagentypene I, II, III, laminln, fibronektiner og andre glykoprotelnkompo- nenter som fremmer leging av sår og som fjerner antigene seter i det cellulære laget som kan utløse en immunrespons. Det amnlotlske materialet blir sterili- sert og kan bli kryss-bundet. Det blir anvendt som et enkelt lag på en skadet overflate utsatt for adhesjoner eller dekket på Indre organer utsatt for blødning, og kan bli sydd eller applisert med en flytende anti- adhesiv adjuvant. Podningen kan bli applisert på fuktige og tørre overflater.
NO950667A 1994-02-24 1995-02-22 Amniotisk membranpodning eller belegg for å forhindre adhesjon eller blödning fra indre organer NO950667L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20144294A 1994-02-24 1994-02-24

Publications (2)

Publication Number Publication Date
NO950667D0 NO950667D0 (no) 1995-02-22
NO950667L true NO950667L (no) 1995-08-25

Family

ID=22745831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950667A NO950667L (no) 1994-02-24 1995-02-22 Amniotisk membranpodning eller belegg for å forhindre adhesjon eller blödning fra indre organer

Country Status (11)

Country Link
EP (1) EP0669138A3 (no)
JP (1) JPH0833702A (no)
KR (1) KR950031094A (no)
CN (1) CN1115673A (no)
AU (1) AU1343195A (no)
CA (1) CA2143063A1 (no)
FI (1) FI950838L (no)
IL (1) IL112580A0 (no)
NO (1) NO950667L (no)
RU (1) RU95102667A (no)
ZA (1) ZA951370B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
CA2173508A1 (en) * 1995-03-31 1996-10-01 Tooru Yui Medical device and method for producing the same
JPH09122225A (ja) * 1995-10-31 1997-05-13 Bio Eng Lab:Kk 医用材料の原料膜材およびその製造方法
JPH09122227A (ja) * 1995-10-31 1997-05-13 Bio Eng Lab:Kk 医用材料およびその製造方法
JP3476631B2 (ja) * 1995-12-21 2003-12-10 株式会社アムニオテック ヒト由来の天然コラーゲン膜からなる医用材料
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
US6152142A (en) * 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
KR100469661B1 (ko) * 2000-03-28 2005-02-02 한스바이오메드 주식회사 이식용 무세포 진피층 및 이의 제조방법
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
CN100368534C (zh) * 2003-05-01 2008-02-13 四川大学华西医院 生物衍生羊膜、复合生物衍生羊膜及其制备方法
ES2396689T3 (es) 2003-12-11 2013-02-25 Isto Technologies Inc. Sistema de cartílago particulado
US20050287223A1 (en) * 2004-06-23 2005-12-29 Peyman Gholam A Use of amniotic membrane as biocompatible devices
WO2006090696A1 (ja) * 2005-02-22 2006-08-31 Arblast Co., Ltd. 上皮が除去された羊膜を調製する方法
GB0514567D0 (en) * 2005-07-15 2005-08-24 Univ Nottingham Surgical membrane
EP1916964A4 (en) 2005-08-26 2015-11-04 Zimmer Inc IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
CA2999420A1 (en) 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
US20110129520A1 (en) * 2008-04-25 2011-06-02 Simon Bogdansky Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
EP2717888B1 (en) 2011-06-10 2020-09-09 Tissuetech, Inc. Methods of processing fetal support tissues
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
US9770472B1 (en) 2013-03-08 2017-09-26 Brahm Holdings, Llc Organ jacket and methods of use
EP3000489B1 (en) 2014-09-24 2017-04-05 Sofradim Production Method for preparing an anti-adhesion barrier film
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
CN111359024A (zh) * 2020-03-24 2020-07-03 江西省科星生物工程有限公司 腹腔开放复合生物保护材料
US11826028B2 (en) 2020-06-10 2023-11-28 Ethicon, Inc. Two component sealing systems including synthetic matrices and biosynthetic adhesives for sealing resected surfaces of organs to control bleeding, fluid leaks and air leaks
CN117582556B (zh) * 2024-01-19 2024-03-19 广州瑞泰生物科技有限公司 一种减少生物医用材料抗原性的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2055099A1 (en) * 1991-11-07 1993-05-08 Ronald L. Young Amniotic membrane graft or wrap to prevent adhesions or bleeding of internal organs

Also Published As

Publication number Publication date
CA2143063A1 (en) 1995-08-25
FI950838A7 (fi) 1995-08-25
CN1115673A (zh) 1996-01-31
IL112580A0 (en) 1995-05-26
JPH0833702A (ja) 1996-02-06
ZA951370B (en) 1996-08-20
RU95102667A (ru) 1997-02-27
AU1343195A (en) 1995-08-31
FI950838A0 (fi) 1995-02-23
FI950838L (fi) 1995-08-25
EP0669138A3 (en) 1996-02-14
KR950031094A (ko) 1995-12-18
EP0669138A2 (en) 1995-08-30
NO950667D0 (no) 1995-02-22

Similar Documents

Publication Publication Date Title
NO950667L (no) Amniotisk membranpodning eller belegg for å forhindre adhesjon eller blödning fra indre organer
Chvapil Considerations on manufacturing principles of a synthetic burn dressing: a review
Pereira et al. Effect of alternative crosslinking methods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material
JP3542170B2 (ja) 医用材料及びその製造方法
ATE273035T1 (de) Hämostatisches pflaster
TW369414B (en) Bone formation transplant
DK1709981T3 (da) Collagenholdige membraner til anvendelse af slimhinde-regeneration
SE7908313L (sv) I kroppen resorberbar formad massa pa basis av kollagen och anvendningen derav inom medicinen
DK0536186T3 (da) Knogle- og brusk-dannelsesfremkaldende proteiner
MX165863B (es) Barrera que evita la adhesion, que contiene heparina y procedimiento para prepararla
CA2185537A1 (en) Heat treated high lignin content cellulosic fibers
ATE204767T1 (de) Verfahren zur verhinderung der verkalkung von aldehyd-fixierten bioprothesenmaterialien
ES2122077T3 (es) Procedimiento para la acetilacion de la madera.
RU2003108842A (ru) Способ ускорения заживления кожи
MY114830A (en) Reduced curl battery separator and method.
ES546100A0 (es) Aparato de tratamiento en discontinuo de legumbres y o hor- talizas,principalmente de champinones o setas.
KR950016844A (ko) 복합반투막의 제조방법
DE69029969D1 (de) Kunsthaut
RU2438713C2 (ru) Биологическое раневое покрытие и способ его изготовления
DE3785581D1 (de) Biovertraegliches material zur behandlung von fehlern in geweben und organen.
EP0943345A4 (en) ARTIFICIAL EYES
DE69231916D1 (de) Makroskopisch orientiertes zelladhäsionsprotein zur wundbehandlung
SE8301595D0 (sv) Peau artificielle
JP5578874B2 (ja) 生体吸収性自己接着型癒着防止材料
DE69516475D1 (de) Verfahren zur Herstellung von reinem Nizatidin